Project title: NOVEL THROMBOLYTIC AGENT

Company name : THROMBOTECH LTD.

TECHNOLOGICAL FIELD
Biopharmaceuticals

KEY WORDS
Thrombolytic Therapy, Acute
Myocardial Infraction, AMI, Ischemic Stroke, Pro-Urokinase,
Single Chain Urokinase, Plasminogen Activator, Clot Buster, Tpa,
Abbokinase, Pre-Clinical, Regulatory, Biotechnology, Recombinant
Technology

PROJECT SUMMARY
THROMBOTECH is developing a series of new and improved
thrombolytic agents that can easily, without side effects,
dissolve newly formed blood clots.

These new and innovative qualities can treat patients that
previously had no treatment (as in stroke) and offer a better and
safer mode of therapy, as in the case of Heart attack (AMI).

ENTREPRENEUR
Dr. Abd Higazi - Expert in the field of
Thrombolytics.

PROJECT STATUS
The company has graduated from the incubator.

COOPERATION REQUIRED
Strategic partnership, Licensing partners, Capital investment.
-----------------------------------------------------------------
E-MAIL: home@naiot.com; muriel@oferhitech.com

Request for more information, about this project.

Note - you have to be registered in this server to request information. If you haven't done so yet, please:
Register in this server and your requests will be forwarded to the developer, who will contact you directly

List of projects that you already requested more information about